These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4676543)

  • 1. Functional capacity of cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J; Fletcher F
    Natl Cancer Inst Monogr; 1972 Dec; 35():243-9. PubMed ID: 4676543
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional efficiency of antitumor cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):317-23. PubMed ID: 4710039
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for the suppression of the development of cytotoxic lymphoid cells in tumor immunized mice.
    Martin WJ; Esber E; Wunderlich JR
    Fed Proc; 1973 Feb; 32(2):173-9. PubMed ID: 4688656
    [No Abstract]   [Full Text] [Related]  

  • 5. Non-reactivity of incompatible lymphoid cells from f1 modified radiation chimeras to host tumour cells in vitro.
    Grant CK; Ilbery PL
    Biomedicine; 1973 Feb; 19(2):56-60. PubMed ID: 4581503
    [No Abstract]   [Full Text] [Related]  

  • 6. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative importance of viral and neoantigens in cytotoxic reaction against murine leukaemia cells.
    Cohen MH; Sibal LR; Fink MA
    Immunology; 1974 Jan; 26(1):37-48. PubMed ID: 4367312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells.
    Ting CC; Rodrigues D
    J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitivity of target cells to the cytotoxic effects of lymphocytes induced by interferon.
    Slavina EG; Leneva NV; Svet-Moldavsky GJ
    Folia Biol (Praha); 1974; 20(4):231-7. PubMed ID: 4370360
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the induction and expression of T cell-mediated immunity. II. Antiserum blocking of cell-mediated cytolysis.
    Bonavida B
    J Immunol; 1974 Apr; 112(4):1308-21. PubMed ID: 4592598
    [No Abstract]   [Full Text] [Related]  

  • 11. In situ lymphoid cells of mouse mammary tumors. III. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors.
    Blazar BA; Miller FR; Heppner GH
    J Immunol; 1978 Jun; 120(6):1887-91. PubMed ID: 659883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-mediated immunologic depression.
    Colmerauer ME; Rumi L; Saal F; Pasqualini CD; Rabasa SL
    J Immunol; 1973 Sep; 111(3):743-9. PubMed ID: 4741295
    [No Abstract]   [Full Text] [Related]  

  • 13. Phagocytic cells as effectors in a cell-mediated immunity system.
    Dennert G; Lennox ES
    J Immunol; 1973 Dec; 111(6):1844-54. PubMed ID: 4543031
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
    Todd RF; Stulting RD; Berke G
    Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies of the induction and expression of T cell mediated immunity. VI. Heterogeneity of lytic efficiency exhibited by isolated cytotoxic T lymphocytes prepared from highly enriched populations of effector-target conjugates.
    Grimm EA; Bonavida B
    J Immunol; 1977 Sep; 119(3):1041-7. PubMed ID: 302269
    [No Abstract]   [Full Text] [Related]  

  • 16. The occurrence of two types of cytotoxic lymphoid cells in mice immunised with allogeneic tumour cells.
    Denham S; Grant CK; Hall JG; Alexander P
    Transplantation; 1970 Apr; 9(4):366-82. PubMed ID: 5534489
    [No Abstract]   [Full Text] [Related]  

  • 17. The occurrence of tow types of cytotoxic lymphoid cells in mice immunised with allogeneic tumour cells.
    Denham S; Grant CK; Hall JG; Alexander P
    Transplantation; 1970 Apr; 9(4):366-82. PubMed ID: 5534104
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
    J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
    Jorgensen PN; Florentz K; Güttler F
    Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of murine large granular lymphocytes. II. Tissue, strain, and age distributions of LGL and LAL.
    Itoh K; Suzuki R; Umezu Y; Hanaumi K; Kumagai K
    J Immunol; 1982 Jul; 129(1):395-405. PubMed ID: 7086138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.